Most group practice owners think about a future sale from the inside out. They ask what their practice is worth, what needs to be fixed, and what the process looks like. Those are the right questions, but they are not the ones a buyer is asking.

A sophisticated buyer, whether a private equity-backed behavioral health platform, a regional healthcare network, or a larger group practice operator, evaluates your practice through a very specific lens. They are building a risk model. They are looking for signals that tell them whether the business is worth what you are asking, whether it will hold its value after you leave, and whether the growth story you are telling them is real.

Understanding that lens is one of the most useful things a practice owner can do, regardless of how far away a sale might be. What buyers see in your practice today is also what determines your options when the time comes.

At Brighter Horizons Practice Solutions, I help owners understand and improve their position through that lens, working alongside M&A brokers and investment bankers who manage the transaction. 

This article walks through what buyers notice about your mental health group practice, and what the signals in your practice are telling them right now. 

 

Buyers Are Building a Risk Model, Not Just Reviewing Your Financials

The first thing to understand about how buyers think is that every piece of information they gather, including financial, operational, clinical, and cultural, is being fed into a risk assessment. 

The central question they are trying to answer is not “Is this a good practice?” It is “What is the probability that this practice performs as well or better after we own it as it does today?”

That distinction matters because it changes what they care about. A practice can have strong revenue and still be perceived as high-risk if that revenue is fragile. A practice can have modest top-line numbers and still be very attractive if the revenue is stable, diversified, and clearly not dependent on the current owner.

How Risk Perception Affects Valuation

Buyers typically apply a multiple to adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) to arrive at a valuation. That multiple is not fixed. It moves based on perceived risk.

A practice that scores well on transferability, financial transparency, operational independence, and growth potential will attract a higher multiple than a comparable practice where those factors are uncertain. 

The difference between a 4x and a 6x EBITDA multiple on the same earnings number is not trivial. At $500,000 in adjusted EBITDA, that gap is $1,000,000 in purchase price.

Understanding what drives that multiple (and what suppresses it) is one of the most financially important things a practice owner can internalize before going to market.

 

What Buyers See in Your Financials

Buyers do not just want to see strong financials. They want financials that tell a clear, consistent, and defensible story. The difference matters more than most owners realize.

The First Signal: Can You Explain Your Own Numbers?

One of the earliest signals in any buyer conversation is whether the owner can speak fluently about their financial performance. 

Owners who can explain revenue trends, margin fluctuations, and expense drivers with clarity project confidence. Owners who cannot, even if the numbers themselves are strong, create doubt.

Buyers interpret financial haziness or opacity as risk, whether it reflects actual problems or simply disorganization. Either way, it affects their posture at the table.

What Buyers Are Actually Looking For in Your Financial Records

Beyond the topline numbers, a buyer doing serious diligence will examine:

• Adjusted EBITDA, with owner compensation and personal expenses added back clearly
• Revenue concentration: how much flows through a single payer, service line, or clinician
• Accounts receivable aging, which reveals billing efficiency and collection reliability
• Overhead structure and whether expenses are lean relative to revenue
• Cash flow consistency, not just profitability on paper
• Any significant revenue changes year over year, and whether you can explain them

Revenue Concentration Is a Specific Red Flag

Buyers are particularly alert to concentration risk. A practice in which a significant share of revenue flows through a single payer, referral source, or high-producing clinician is inherently fragile. 

If that payer changes contract terms, that referral source retires, or that clinician leaves post-acquisition, the revenue picture changes materially.

Buyers will either price that risk into a lower multiple or ask for deal structures, such as earnouts, that shift some of that risk back to the seller.

 

What Buyers See When They Evaluate Owner Dependency

This is possibly the single most important factor in a group practice sale, and the one that most frequently surprises owners when they first encounter it.

From a buyer’s perspective, a practice where the founder is the primary referral source, the de facto clinical supervisor, the institutional memory, and the final decision-maker on operational questions is not a business. It is a job, and they are being asked to pay a business price for it.

The Question Buyers Are Actually Asking

When a buyer evaluates owner dependency, they are trying to answer: “If this person is gone six months after closing, what happens to the practice?”

They are looking for evidence that the answer is “not much”—that systems run without the owner’s intervention, that a leadership layer exists to make and implement decisions, and that clinical quality does not depend on the founder’s direct involvement.

How Owner Dependency Affects Deal Structure, Not Just Valuation

High owner dependency does not always kill a deal, but it shapes how a deal gets structured. 

Buyers managing this risk may require longer post-sale employment or consulting agreements, earnout provisions tied to post-close performance, or price adjustments that reflect the transition risk they are absorbing.

In other words, the owner who is deeply embedded in daily operations does not just receive a lower multiple; they may also face deal terms that delay or create contingencies on a portion of their proceeds.

 

What Buyers See in Your Operations and Infrastructure

Buyers with acquisition experience know that operational infrastructure determines whether a practice maintains its performance during a transition. They are looking for evidence that the business runs on systems, not on people, and that those systems are documented well enough to survive leadership changes.

Intake and Billing: The Two Areas That Receive the Most Scrutiny

In diligence, intake, and billing, attention tends to be disproportionate — and for good reason. They are the two operational areas most directly connected to revenue integrity.

A buyer reviewing intake data wants to understand conversion rates from inquiry to scheduled appointment, how consistently that process runs, and how much revenue is being lost to poor follow-up or scheduling gaps. 

A buyer reviewing billing wants to understand denial rates, collection rates, accounts receivable aging, and whether the revenue on paper is actually being collected.

Weaknesses in either area raise a specific concern: if the practice is leaking revenue now, under the current owner’s supervision, what happens after a transition?

Documented Systems as a Transferability Signal

Buyers evaluate documentation not as a paperwork exercise, but as evidence of transferability. A practice where hiring, onboarding, scheduling, billing, and clinical supervision protocols are documented and consistently followed can be handed off. A practice where those processes live primarily in the owner’s head transfers poorly.

The question buyers ask is not “Do they have good systems?” It is “Could someone new run this practice without significant disruption?” Documentation is the evidence that answers that question.

Clinician Classification: W2 vs. 1099

Buyer preference for W2 employees over 1099 independent contractors is not simply philosophical. It reflects concrete concerns about operational control, consistency of clinical standards, and legal exposure during and after the acquisition.

Practices with a heavy 1099 structure often carry misclassification risk that surfaces in diligence. They also tend to have weaker mechanisms for enforcing clinical standards, managing performance, and optimizing compensation systems — all of which matter to buyers considering post-acquisition quality, liability, and profitability.

 

What Buyers See in Your Culture and Team

Experienced acquirers know that culture is one of the hardest things to assess from the outside and one of the most expensive things to repair after a deal closes. They will look for signals in both what you tell them and what the data show.

Clinician Turnover as a Financial Signal

High clinician turnover is not just a culture problem; it is a financial problem that buyers will quantify. Every clinician departure represents lost caseload revenue, recruitment and onboarding costs, and a disruption to client relationships. 

A practice with consistently high churn has a structural cost that does not show up cleanly on an income statement but will absolutely be identified in diligence.

Buyers will examine turnover rates, tenure distribution, and exit patterns. A stable team with long tenure signals healthy leadership and a working environment that retains people. It also signals that the revenue base is less fragile than it would be with a revolving clinical staff.

What Buyers Cannot Easily Measure — But Can Sense

Beyond the data, buyers conducting site visits and leadership conversations are picking up qualitative signals about whether the culture will survive a transition. 

Do the clinical leaders speak confidently about the organization’s direction? Is there alignment between what the owner says and what the team reflects? Is there a leadership layer that seems capable of carrying the mission forward?

These signals are harder to quantify, but they are not ignored. A practice in which the culture is visibly dependent on the founder’s personal presence raises transition risk, even if the financials are strong.

 

What Buyers See in Your Growth Story

Buyers are not just acquiring what your practice is today. They are acquiring a platform for what it could become under their ownership. A practice with a credible, near-term growth narrative is worth more than an equivalent practice that appears to have reached its ceiling.

What Makes a Growth Story Credible to a Buyer

The keyword is credible. Buyers have seen enough optimistic projections to be skeptical of growth narratives that lack operational grounding. The growth opportunities that resonate are the ones that are identifiable, near-term, and clearly connected to existing strengths:

• A waitlist or unmet demand that additional clinician capacity could absorb
• A service line that existing infrastructure could support without significant reinvestment
• A geographic market, the practice is positioned to enter
• Payer relationships that are underutilized relative to the practice’s clinical capacity
• Referral pipelines that are strong but not yet fully developed

A practice that can show a buyer not just what has been built but where the next phase of growth will come from — and why it is achievable with their resources behind it — commands a premium.

 

What Buyers See That Most Owners Do Not Expect Them to See

One of the most valuable things I do with practice owners preparing for a sale is walk them through what a buyer will find in diligence that the owner did not think to flag. This is not about hiding problems. It is about understanding your own practice clearly enough to get ahead of the narrative.

Common examples include:

• Owner-related expenses — compensation, benefits, or personal expenses run through the business — that need to be identified and added back to calculate a normalized EBITDA
• Overhead that appears higher than industry norms in areas such as clinical payroll structures and marketing spend that may need context or explanation — buyers will want to understand whether these reflect sustainable, normalized costs or outliers tied to the current ownership model
• Referral concentration that the owner has never thought of as a risk because the relationship feels durable to them, but looks fragile to a buyer who does not share that relationship
• A key clinician whose departure post-acquisition would materially affect revenue, and who has no contractual or structural retention mechanism in place
• Compliance gaps in documentation, billing, or credentialing that have never caused a problem but would require remediation before or after closing
• Informal processes that work because of the owner’s presence and judgment, but have never been written down or tested without them

None of these issues is necessarily fatal to a deal. But each one is better addressed before diligence than discovered during it. Buyers who find problems in diligence either reprice or re-trade. Sellers who surface and explain issues proactively retain credibility and control.

 

How Brighter Horizons Practice Solutions Fits Into This Process

A skilled M&A broker or investment banker manages the transaction mechanics — buyer identification, CIM preparation, negotiation, and closing. That expertise is essential, and I encourage every owner I work with to engage qualified transaction professionals when the time comes.

What I offer is different and complementary. I work with practice owners at the strategic and operational level to help them understand their practice through the buyer’s lens before going to market — and to close the gaps that affect multiples, deal structure, and leverage at the table.

That work includes:

• Assessing owner dependency, operational infrastructure, financial transparency, and culture against buyer expectations
• Identifying the specific factors in your practice that are likely to suppress valuation or complicate deal structure
• Building the systems, documentation, and leadership infrastructure that improve transferability
• Helping you understand the landscape of buyer types and what each one is likely to prioritize and scrutinize
• Preparing you to navigate the emotional dimensions of an exit that a transaction advisor is not positioned to address

 

I sold a 60+-clinician group practice in 2021 and remained engaged throughout the post-sale transition and the integration of three additional practices in a roll-up. I have sat across from buyers and experienced this evaluation process firsthand — including the parts that follow once the paperwork is signed. That perspective is what I bring to this work.